Global Health

More from the Series

Blog Post
Partnerships, Political Will, and Proof: Takeaways from the "Millions Saved" Launch Event
Lauren Post
April 19, 2016
Blog Post
Congressional Panel Looks to Learn from Ebola
Erin Collinson
and
Sarath Ganji
April 14, 2016
Blog Post
A New Language for Global Mental Health: Economics
Victoria de Menil
and
Amanda Glassman
April 13, 2016
TESTIMONY
Testimony on the US Response to the Ebola Epidemic in West Africa
Amanda Glassman
April 08, 2016
On April 7, 2016, CGD’s vice president for programs and director of global health policy Amanda Glassman testified before the Senate Foreign Relations Subcommittee on Africa and Global Health Policy at a hearing examining progress made in addressing the West Africa Ebola epidemic and its s...

May

9

2016



5:30—5:30 PM
Book Launch in London, UK: Proven Success in Global Health: What's Worked, What Hasn't, and Why Knowing Matters
Amanda Glassman
April 07, 2016
Over the past 15 years, people in low- and middle-income countries have experienced a health revolution - one that has created new opportunities and brought new challenges. It is a revolution that keeps mothers and babies alive, helps children grow, and enables adults to thrive.
Blog Post
Millions Saved: What Works in Global Health? – Podcast with Amanda Glassman
Rajesh Mirchandani
April 04, 2016
Millions Saved rigorously evaluates 22 programs from Haiti to Botswana, Peru to Pakistan, in order to understand what works in global health and why. Coauthor Amanda Glassman visits the CGD Podcast to share some of the book’s cases and takeaways. 
Blog Post
What Drug Patents Do Is Complicated: A Belated Contribution from Jenny Lanjouw Helps Sort It Out
Kimberly Ann Elliott
April 04, 2016
When it comes to the challenge of ensuring access to medicines in developing countries, three distinct issues often get conflated: innovation, availability, and affordability. Recent research from CGD alums offers new insight into the complicated dynamics at play at the core of a hot debate.